Literature DB >> 8438200

Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988.

N F Ray1, J W Larsen, R J Stillman, R J Jacobs.   

Abstract

Much has been written about adhesion formation and prevention. Little is known about the number and cost of hospitalizations during which adhesiolysis is performed. This report describes the number of hospitalizations and days of care attributable to adhesiolysis in the United States and estimates the costs associated with these stays. The cost per hospital day and associated surgeons' fees are based on prevailing nationwide charges. During 1988, there were 281,982 hospitalizations during which adhesiolysis was performed, accounting for 948,727 days of inpatient care. These hospitalizations were responsible for an estimated $1,179.9 million in expenditures, of which $925.0 million was associated with hospital costs and $254.9 million with surgeons' fees. This estimate does not include outpatient costs and indirect costs. The results of this study demonstrate substantial costs associated with hospitalizations for adhesiolysis. Further understanding and prevention of adhesions may help to reduce unnecessary morbidity and mortality rates.

Entities:  

Mesh:

Year:  1993        PMID: 8438200

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  37 in total

1.  Quantitative analysis of the development of experimentally induced post surgical adhesions: a microstereological study.

Authors:  S A Ricketts; P D Sibbons; C J Green
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial.

Authors:  Wietske W Vrijland; Larissa N L Tseng; Heert J M Eijkman; Wim C J Hop; Jack J Jakimowicz; Piet Leguit; Laurents P S Stassen; Dingeman J Swank; Robert Haverlag; H Jaap Bonjer; Hans Jeekel
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 3.  Abdominal adhesions: intestinal obstruction, pain, and infertility.

Authors:  W W Vrijland; J Jeekel; H J van Geldorp; D J Swank; H J Bonjer
Journal:  Surg Endosc       Date:  2003-03-14       Impact factor: 4.584

4.  Resistance to adhesion formation: a comparative study of treated and untreated mesh products placed in the abdominal cavity.

Authors:  R Gonzalez; G T Rodeheaver; D L Moody; P A Foresman; B J Ramshaw
Journal:  Hernia       Date:  2004-03-18       Impact factor: 4.739

Review 5.  Prevention of peritoneal adhesions: a promising role for gene therapy.

Authors:  Hussein M Atta
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

Review 6.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

Review 7.  Pathophysiology and prevention of postoperative peritoneal adhesions.

Authors:  Willy Arung; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

8.  Effects of peritoneal lavage with scolicidal agents on survival and adhesion formation in rats.

Authors:  Omer Topcu; Isinsu Kuzu; Kaan Karayalcin
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

9.  The use of statins in postoperative adhesion prevention.

Authors:  J B C van der Wal; J Jeekel
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

10.  Sodium hyaluronate-based bioresorbable membrane (Seprafilm) reduced early postoperative intestinal obstruction after lower abdominal surgery for colorectal cancer: the preliminary report.

Authors:  Chi-Min Park; Woo Yong Lee; Yong Beom Cho; Hae Ran Yun; Won-Suk Lee; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2008-10-25       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.